Paper37037178
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
Shirasawa M and 21 others. Lung Cancer, 2023. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. Papers, record 37037178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37037178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Small Cell Lung Carcinoma | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Etoposide | |
| Retrospective Studies | |
| Phenotype |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42705850 | [Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer Based on Molecular Subtyping]. | Zhongguo Fei Ai Za Zhi | 2026 | https://conductscience.org/library/papers/42705850 | PubMed |
| 42701198 | Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer. | Biomark Res | 2026 | https://conductscience.org/library/papers/42701198 | PubMed |
| 42291341 | Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42291341 | PubMed |
| 41783745 | Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study. | JTO Clin Res Rep | 2026 | https://conductscience.org/library/papers/41783745 | PubMed |
| 41454081 | Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy. | Front Med | 2025 | https://conductscience.org/library/papers/41454081 | PubMed |
| 41446220 | CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level. | bioRxiv | 2025 | https://conductscience.org/library/papers/41446220 | PubMed |
| 41220942 | Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/41220942 | PubMed |
| 41220940 | A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America. | Front Oncol | 2025 | https://conductscience.org/library/papers/41220940 | PubMed |
| 41187938 | TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/41187938 | PubMed |
| 41132975 | Metabolic phenotype and gender may predict treatment outcomes of atezolizumab in extensive-stage small cell lung cancer. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/41132975 | PubMed |
| 41001033 | Case Report: A small cell lung cancer transformed from an EGFR-mutated Adenocarcinoma demonstrated a long-term remission to anti PD-1 antibody. | Front Oncol | 2025 | https://conductscience.org/library/papers/41001033 | PubMed |
| 40964483 | State of the art in treatment of small cell lung cancer. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/40964483 | PubMed |
| 40931642 | Prognostic values and clinical significance of POU2F3 expression in neuroendocrine carcinomas: a meta-analysis with a focus on small cell lung cancer. | Ann Med | 2025 | https://conductscience.org/library/papers/40931642 | PubMed |
| 40543507 | MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40543507 | PubMed |
| 40386726 | Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/40386726 | PubMed |
| 40333678 | Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives. | Molecules | 2025 | https://conductscience.org/library/papers/40333678 | PubMed |
| 39941061 | The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39941061 | PubMed |
| 39789380 | Adoptive cell therapies in thoracic malignancies: a comprehensive review. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/39789380 | PubMed |
| 39723215 | Advances in biomarkers for immunotherapy in small-cell lung cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39723215 | PubMed |
| 39682568 | Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39682568 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| ASCL1 | 429 | PubTator's text mining | https://conductscience.org/library/genes/429 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| NEUROD1 | 4760 | PubTator's text mining | https://conductscience.org/library/genes/4760 | NCBI Gene |
| POU2F3 | 25833 | PubTator's text mining | https://conductscience.org/library/genes/25833 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37037178
GET https://conductscience.org/api/papers/v1/37037178/authors?page=2